Use of autoantibodies to detect the onset of breast cancer

Journal of Immunology Research

Volumn 2014, Issue , 2014, Pages

  Lacombe, Jérôme ^a   Mangé, Alain ^b,c,d   Solassol, Jérôme ^b,c,d  

^a INSERM   (France)

^b MONTPELLIER UNIVERSITY HOSPITAL   (France)

^c UNIV MONTPELLIER   (France)

^d CENTRE VAL D AURELLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; TUMOR ANTIGEN; TUMOR MARKER;

ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; BREAST CANCER; CANCER DIAGNOSIS; CANCER SCREENING; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE RESULT; HUMAN; REVIEW; SENSITIVITY AND SPECIFICITY; BREAST NEOPLASMS; DIAGNOSTIC USE; FEMALE; IMMUNOLOGY; PATHOLOGY;

ANTIGENS, NEOPLASM; AUTOANTIBODIES; BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; TUMOR MARKERS, BIOLOGICAL;

EID: 84925467951     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2014/574981     Document Type: Review

References (41)

1. J. Ferlay, H. R. Shin, F. Bray, D. Forman, C. Mathers, and D. M. Parkin, "Estimates of worldwide burden of cancer in 2008: GLOBOCAN2008, " International Journal ofCancer, vol. 127, no. 12, pp. 2893-2917, 2010.
2. M. T. Mandelson, N. Oestreicher, P. L. Porter, et al., "Breast density as a predictor ofmammographic detection: comparison of interval-and screen-detected cancers, " Journal of the National Cancer Institute, vol. 92, no. 13, pp. 1081-1087, 2000.
3. A. Bleyer and H. G. Welch, "Effect of three decades of screening mammography on breast-cancer incidence, " The New England Journal of Medicine, vol. 367, no. 21, pp. 1998-2005, 2012.
4. F. M. Hall, "Breast imaging and computer-aided detection, " The NewEngland Journal ofMedicine, vol. 356, no. 14, pp. 1464-1466, 2007.
5. C. D. Lehman, "Magnetic resonance imaging in the evaluation of ductal carcinoma in situ, " Journal of the National Cancer Institute Monographs, vol. 2010, no. 41, pp. 150-151, 2010.
6. W. T. Yang, "Emerging techniques and molecular imaging in breast cancer, " Seminars in Ultrasound, CT andMRI, vol. 32, no. 4, pp. 288-299, 2011.
7. R. Etzioni, N. Urban, S. Ramsey, et al., "The case for early detection, " Nature Reviews Cancer, vol. 3, no. 4, pp. 243-252, 2003.
8. A. K. Fuzery, J. Levin, M. M. Chan, and D. W. Chan, "Translation of proteomic biomarkers into FDA approved cancer diagnostics: issues and challenges, " Clinical Proteomics, vol. 10, article 13, 2013.
9. C. Desmetz, A. Mange, T. Maudelonde, and J. Solassol, "Autoantibody signatures: progress and perspectives for early cancer detection, " Journal of Cellular and Molecular Medicine, vol. 15, no. 10, pp. 2013-2024, 2011.
10. R. W. Baldwin, "Immunity to transplanted tumour: the effect of tumour extracts on the growth of homologous tumours in rats, " British Journal of Cancer, vol. 9, no. 4, pp. 646-651, 1955.
11. Graham J. B. and R. M. Graham, "Antibodies elicited by cancer in patients, " Cancer, vol. 8, no. 2, pp. 409-416, 1955.
12. G. Taylor and J. L. Odili, "Tumour specific T-like antigen of human breast carcinoma, " British Journal of Cancer, vol. 24, no. 3, pp. 447-453, 1970.
13. E. S. Priori, D. E. Anderson, W. C. Williams, and L. Dmochowski, "Immunological studies on human breast carcinoma and mouse mammary tumors, " Journal of the National Cancer Institute, vol. 48, no. 4, pp. 1131-1135, 1972.
14. J. Wasserman, U. Glas, and H. Blomgren, "Autoantibodies in patients with carcinoma of the breast: correlation with prognosis, " Clinical and Experimental Immunology, vol. 19, no. 3, pp. 417-422, 1975.
15. E. Piura and B. Piura, "Autoantibodies to tumor-associated antigens in breast carcinoma, " Journal of Oncology, vol. 2010, Article ID 264926, 14 pages, 2010.
16. H. Lu, J. Ladd, Z. Feng, et al., "Evaluation of known oncoantibodies, HER2, p53, and cyclin B1, in prediagnostic breast cancer sera, " Cancer Prevention Research, vol. 5, no. 8, pp. 1036-1043, 2012.
17. Y. Sun, R. Zhang, M. Wang, Y. Zhang, J. Qi, and J. Li, "SOX2 autoantibodies as noninvasive serum biomarker for breast carcinoma, " Cancer Epidemiology, Biomarkers&Prevention, vol. 21, no. 11, pp. 2043-2047, 2012.
18. X. Liu, Y. Chai, J. Li, et al., "Autoantibody response to a novel tumor-associated antigen p90/CIP2A in breast cancer immunodiagnosis, " Tumour Biology, vol. 35, no. 3, pp. 2661-2667, 2014.
19. L. Ye, X. Li, S. Sun, et al., "A study of circulating anti-CD25 antibodies in non-small cell lung cancer, " Clinical & Translational Oncology, vol. 15, no. 8, pp. 633-637, 2013.
20. S. Guan, B. Liu, C. Zhang, K.-H. Lee, S. Sun, and J. Wei, "Circulating autoantibody to CD25 may be a potential biomarker for early diagnosis of esophageal squamous cell carcinoma, " Clinical & Translational Oncology, vol. 15, no. 10, pp. 825-829, 2013.
21. L. Ye, S. Guan, C. Zhang, et al., "Circulating autoantibody to FOXP3 may be a potential biomarker for esophageal squamous cell carcinoma, " Tumor Biology, vol. 34, no. 3, pp. 1873-1877, 2013.
22. T. Liu, Y. N. Song, Q. Y. Shi, et al., "Study of circulating antibodies against CD25 andFOXP3 inbreast cancer, " Tumour Biology, vol. 35, no. 4, pp. 3779-3783, 2013.
23. C. K. Heo, H. M. Hwang, A. Ruem, et al., "Identification of a mimotope for circulating anti-cytokeratin 8/18 antibody and its usage for the diagnosis of breast cancer, " International Journal of Oncology, vol. 42, no. 1, pp. 65-74, 2013.
24. C. A. Casiano, M. Mediavilla-Varela, and E. M. Tan, "Tumorassociated antigen arrays for the serological diagnosis of cancer, " Molecular & Cellular Proteomics, vol. 5, no. 10, pp. 1745-1759, 2006.
25. H. T. Tan, J. Low, S. G. Lim, and M. C. M. Chung, "Serum autoantibodies as biomarkers for early cancer detection, " The FEBS Journal, vol. 276, no. 23, pp. 6880-6904, 2009.
26. C. Chapman, A. Murray, J. Chakrabarti, et al., "Autoantibodies in breast cancer: their use as an aid to early diagnosis, " Annals of Oncology, vol. 18, pp. 868-873, 2007.
27. C. Desmetz, C. Bascoul-Mollevi, P. Rochaix, et al., "Identification of a new panel of serum autoantibodies associated with the presence of in situ carcinoma of the breast in younger women, " Clinical Cancer Research, vol. 15, no. 14, pp. 4733-4741, 2009.
28. J. Lacombe, A. Mangé, M. Jarlier, et al., "Identification and validation of new autoantibodies for the diagnosis of DCIS and node negative early-stage breast cancers, " International Journal of Cancer, vol. 132, no. 5, pp. 1105-1113, 2013.
29. H. Ye, C. Sun, P. Ren, et al., "Mini-array of multiple tumorassociated antigens (TAAs) in the immunodiagnosis of breast cancer, " Oncology Letters, vol. 5, no. 2, pp. 663-668, 2013.
30. X. Dong, M. Yang, H. Sunet al., "Combinedmeasurement ofCA 15-3 with novel autoantibodies improves diagnostic accuracy for breast cancer, " OncoTargets andTherapy, vol. 6, pp. 273-279, 2013.
31. J. A. Koziol, J. Y. Zhang, C. A. Casiano, et al., "Recursive partitioning as an approach to selection of immune markers for tumor diagnosis, " Clinical Cancer Research, vol. 9, pp. 5120-5126, 2003.
32. J. Y. Zhang, C. A. Casiano, X. X. Peng, et al., "Enhancement of antibody detection in cancer using panel of recombinant tumor-associated antigens, " Cancer Epidemiology, Biomarkers& Prevention, vol. 12, pp. 136-143, 2003.
33. H. Lu, V. Goodell, and M. L. Disis, "Humoral immunity directed against tumor-associated antigens as potential biomarkers for the early diagnosis of cancer, " Journal of Proteome Research, vol. 7, no. 4, pp. 1388-1394, 2008.
34. L. Zhong, K. Ge, J. C. Zu, et al., "Autoantibodies as potential biomarkers for breast cancer, " Breast Cancer Research, vol. 10, article R40, 2008.
35. A. Mangé, J. Lacombe, C. Bascoul-Mollevi, et al., "Serum autoantibody signature of ductal carcinoma in situ progression to invasive breast cancer, " Clinical Cancer Research, vol. 18, no. 7, pp. 1992-2000, 2012.
36. E. P. Diamandis, "The failure of protein cancer biomarkers to reach the clinic: why, and what can be done to address the problem?" BMC Medicine, vol. 10, article 87, 2012.
37. M. F. Elshal and J. P. McCoy, "Multiplex bead array assays: performance evaluation and comparison of sensitivity to ELISA, " Methods, vol. 38, no. 4, pp. 317-323, 2006.
38. E. C. Farlow, K. Patel, S. Basu, et al., "Development of a multiplexed tumor-associated autoantibody-based blood test for the detection of non-small cell lung cancer, " Clinical Cancer Research, vol. 16, no. 13, pp. 3452-3462, 2010.
39. K. Patel, E. C. Farlow, A. W. Kim, et al., "Enhancement of a multianalyte serum biomarker panel to identify lymph node metastases in non-small cell lung cancer with circulating autoantibody biomarkers, " International Journal of Cancer, vol. 129, no. 1, pp. 133-142, 2011.
40. B. K. Kim, J. W. Lee, P. J. Park, et al., "The multiplex bead array approach to identifying serumbiomarkers associatedwith breast cancer, " Breast Cancer Research, vol. 11, no. 2, article R22, 2009.
41. Z. Yang, Y. Chevolot, T. Géhin, et al., "Improvement of protein immobilization for the elaboration of tumor-associated antigen microarrays: application to the sensitive and specific detection of tumor markers from breast cancer sera, " Biosensors and Bioelectronics, vol. 40, no. 1, pp. 385-392, 2013.